Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors - Contact The Gross Law FirmPRNewsWire • 09/05/24
Levi & Korsinsky Notifies Verve Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – VERVAccesswire • 09/04/24
VERV Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Verve Therapeutics, Inc. Class ActionGlobeNewsWire • 09/04/24
The Schall Law Firm Is Reaching Out To The Public For Assistance With A Lawsuit For Securities Fraud Against Verve Therapeutics IncAccesswire • 09/04/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/04/24
VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmGlobeNewsWire • 09/03/24
REMINDER – Verve Therapeutics, Inc. Investor Alert: Robbins LLP Reminds Shareholders of the VERV Class Action LawsuitBusiness Wire • 09/03/24
Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join - Contact Levi & KorsinskyAccesswire • 09/03/24
Verve Therapeutics Inc. Is Being Sued And Stakeholders With Losses Are Encouraged To Contact The Schall Law FirmAccesswire • 09/03/24
VERVE THERAPEUTICS, INC. (NASDAQ: VERV) INVESTOR ALERT: Investors With Large Losses in Verve Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsGlobeNewsWire • 09/03/24
VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/02/24
Verve Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - VERVAccesswire • 09/01/24
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERVGlobeNewsWire • 09/01/24
Verve Therapeutics Inc. May Have Engaged In Fraudulent Activities And The Public Is Encouraged To Contact The Schall Law Firm About A SuitAccesswire • 09/01/24
The Schall Law Firm Seeks Investors To Help With A Lawsuit Against Verve Therapeutics Inc For Possibly Illegal PracticesAccesswire • 08/31/24
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve TherapeuticsPRNewsWire • 08/31/24
A Case For Fraud Has Been Filed Against Verve Therapeutics Inc And Impacted Shareholders Are Invited To Help The Schall Law FirmAccesswire • 08/30/24
Verve Therapeutics Inc. Is Being Looked Into For Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law FirmAccesswire • 08/29/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 08/29/24
VERVE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Verve Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 08/29/24
VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. in Securities Fraud LawsuitPRNewsWire • 08/28/24
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Verve Therapeutics, Inc.GlobeNewsWire • 08/28/24
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Verve Therapeutics, Inc. (VERV)GlobeNewsWire • 08/28/24
The Schall Law Firm Urges Investors In Verve Therapeutics Inc To Participate In An Investigation Into Potential Securities Law ViolationsAccesswire • 08/28/24